Skip to content

H.R. 5343 · 119th Congress (2025–2027)

Ensuring Patient Access to Critical Breakthrough Products Act

This bill provides for Medicare coverage of medical devices that are approved under the Food and Drug Administration (FDA) Breakthrough Devices Program. (Under the program, manufacturers work with the FDA to expedite the review and approval of certain medical devices that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human diseases or conditions.)

The bill allows designated medical breakthrough devices to be temporarily covered under Medicare during a four-year transitional period. Manufacturers must apply to the Centers for Medicare & Medicaid Services (CMS) to receive this designation. Qualifying devices must (1) have received priority review from the FDA, (2) received premarket approval (if applicable) based on clinical data that includes data from Medicare beneficiaries, (3) already generally qualify for Medicare coverage, and (4) not present an undue risk of harm that outweighs potential clinical benefits for Medicare beneficiaries.

The CMS must approve or deny applications within six months of receipt and must provide an explanation in the case of a denial. In addition, the CMS must make permanent coverage decisions before the end of the transitional period upon a timely request to do so, as specified.

The bill provides funds through FY2030 for the CMS to implement the bill.

Show official title

To amend title XVIII of the Social Security Act to ensure prompt coverage of breakthrough devices under the Medicare program.

Ordered to be reported

Latest actionOrdered reported

This bill’s path

This is H.R. 5343’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Blake D. Moore (R-UT-1)
Cosponsors
68 cosponsors

5 original · 63 later

35 R · 33 D

  1. Rep. Gus M. Bilirakis (R-FL-12)· Original · Sep 15, 2025
  2. Rep. Suzan K. DelBene (D-WA-1)· Original · Sep 15, 2025
  3. Rep. Terri A. Sewell (D-AL-7)· Original · Sep 15, 2025
  4. Rep. Lori Trahan (D-MA-3)· Original · Sep 15, 2025
  5. Rep. Rudy Yakym III (R-IN-2)· Original · Sep 15, 2025
  6. Rep. Michelle Fischbach (R-MN-7)· Later · Sep 16, 2025
  7. Rep. Claudia Tenney (R-NY-24)· Later · Sep 16, 2025
  8. Rep. Bradley Scott Schneider (D-IL-10)· Later · Sep 17, 2025
  9. Rep. J. Luis Correa (D-CA-46)· Later · Sep 19, 2025
  10. Rep. Jake Auchincloss (D-MA-4)· Later · Oct 31, 2025
  11. Rep. Earl L. "Buddy" Carter (R-GA-1)· Later · Oct 31, 2025
  12. Rep. Ted Lieu (D-CA-36)· Later · Nov 7, 2025
  13. Rep. Carol D. Miller (R-WV-1)· Later · Nov 7, 2025
  14. Rep. Ami Bera (D-CA-6)· Later · Nov 18, 2025
  15. Rep. Burgess Owens (R-UT-4)· Later · Nov 18, 2025
  16. Rep. Darren Soto (D-FL-9)· Later · Dec 2, 2025
  17. Rep. Randy K. Weber, Sr. (R-TX-14)· Later · Dec 2, 2025
  18. Rep. Jennifer A. Kiggans (R-VA-2)· Later · Dec 9, 2025
  19. Rep. Chris Pappas (D-NH-1)· Later · Dec 9, 2025
  20. Rep. Aaron Bean (R-FL-4)· Later · Dec 17, 2025
  21. Rep. Jimmy Panetta (D-CA-19)· Later · Jan 6, 2026
  22. Rep. Cliff Bentz (R-OR-2)· Later · Jan 14, 2026
  23. Rep. Deborah K. Ross (D-NC-2)· Later · Jan 14, 2026
  24. Rep. Mike Carey (R-OH-15)· Later · Feb 3, 2026
  25. Rep. Josh Gottheimer (D-NJ-5)· Later · Feb 3, 2026
  26. Rep. Michael Lawler (R-NY-17)· Later · Feb 3, 2026
  27. Rep. Nicole Malliotakis (R-NY-11)· Later · Feb 3, 2026
  28. Rep. Brittany Pettersen (D-CO-7)· Later · Feb 3, 2026
  29. Rep. Marilyn Strickland (D-WA-10)· Later · Feb 3, 2026
  30. Rep. Brian K. Fitzpatrick (R-PA-1)· Later · Feb 10, 2026
  31. Rep. Zoe Lofgren (D-CA-18)· Later · Feb 10, 2026
  32. Rep. Steve Cohen (D-TN-9)· Later · Feb 11, 2026
  33. Rep. Chrissy Houlahan (D-PA-6)· Later · Feb 11, 2026
  34. Rep. John Joyce (R-PA-13)· Later · Feb 11, 2026
  35. Rep. Celeste Maloy (R-UT-2)· Later · Feb 11, 2026
  36. Rep. Angie Craig (D-MN-2)· Later · Mar 16, 2026
  37. Rep. Daniel Meuser (R-PA-9)· Later · Mar 16, 2026
  38. Rep. David G. Valadao (R-CA-22)· Later · Apr 2, 2026
  39. Rep. George Whitesides (D-CA-27)· Later · Apr 2, 2026
  40. Rep. Brendan F. Boyle (D-PA-2)· Later · Apr 9, 2026
  41. Rep. Jason Crow (D-CO-6)· Later · Apr 9, 2026
  42. Rep. Juan Ciscomani (R-AZ-6)· Later · Apr 9, 2026
  43. Rep. Jay Obernolte (R-CA-23)· Later · Apr 9, 2026
  44. Rep. Maggie Goodlander (D-NH-2)· Later · Apr 16, 2026
  45. Rep. Mike Kennedy (R-UT-3)· Later · Apr 16, 2026
  46. Rep. Gregory F. Murphy (R-NC-3)· Later · May 14, 2026
  47. Rep. Kevin Mullin (D-CA-15)· Later · May 14, 2026
  48. Rep. Sharice Davids (D-KS-3)· Later · May 19, 2026
  49. Rep. David Kustoff (R-TN-8)· Later · May 19, 2026
  50. Rep. Sam T. Liccardo (D-CA-16)· Later · May 20, 2026
  51. Rep. John H. Rutherford (R-FL-5)· Later · May 20, 2026
  52. Rep. Nanette Diaz Barragán (D-CA-44)· Later · Jun 29, 2026
  53. Rep. Maria Elvira Salazar (R-FL-27)· Later · Jun 29, 2026
  54. Rep. Kevin Hern (R-OK-1)· Later · Jun 30, 2026
  55. Rep. Mike Kelly (R-PA-16)· Later · Jun 30, 2026
  56. Rep. Frank J. Mrvan (D-IN-1)· Later · Jun 30, 2026
  57. Rep. Young Kim (R-CA-40)· Later · Jul 13, 2026
  58. Rep. Richard McCormick (R-GA-7)· Later · Jul 13, 2026
  59. Rep. Scott H. Peters (D-CA-50)· Later · Jul 13, 2026
  60. Rep. Mary Gay Scanlon (D-PA-5)· Later · Jul 13, 2026
  61. Rep. Neal P. Dunn (R-FL-2)· Later · Jul 20, 2026
  62. Rep. Haley M. Stevens (D-MI-11)· Later · Jul 20, 2026
  63. Rep. Madeleine Dean (D-PA-4)· Later · Aug 3, 2026
  64. Rep. Thomas H. Kean, Jr. (R-NJ-7)· Later · Aug 3, 2026
  65. Rep. Nicholas A. Langworthy (R-NY-23)· Later · Aug 31, 2026
  66. Rep. Jack Bergman (R-MI-1)· Later · Oct 22, 2026
  67. Rep. Adrian Smith (R-NE-3)· Later · Oct 22, 2026
  68. Rep. Shri Thanedar (D-MI-13)· Later · Oct 22, 2026
Policy area
Health
Subjects
  • Congressional oversight
  • Drug safety, medical device, and laboratory regulation
  • Health care costs and insurance
  • Health care coverage and access
  • Health programs administration and funding
  • Health technology, devices, supplies
  • Medicare

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 3 committee actions · Sep 15, 2025 – Sep 17, 2025
    1. Referred to committee

      Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

      Sources
    2. Markup session held

      Committee Consideration and Mark-up Session Held

      Sources
    3. Ordered reported

      Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.

      Sources

Committees

  1. HouseEnergy and CommerceReferred Sep 15, 2025
  2. HouseWays and MeansReferred Sep 15, 2025 · Markup Sep 17, 2025
    1. Sep 17, 2025 · Markup

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Ensuring Patient Access to Critical Breakthrough Products Act

    Display title, Short title · Introduced in House

  2. To amend title XVIII of the Social Security Act to ensure prompt coverage of breakthrough devices under the Medicare program.

    Official title · Introduced in House